The Patent Finder

Step Pharma S.A.S.

Also on record
Records under this name other than the patents Step Pharma S.A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 10 of 10 · Back to Step Pharma S.A.S.

PatentTitleStatus Expires Confidence
US 11,987,573Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors
In force
 · High confidence
In forceHigh confidence
16/982,641Compounds
Abandoned
Abandoned Nov 9, 2022
AbandonedAbandoned Nov 9, 2022
17/615,879N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases
Abandoned
Abandoned Feb 18, 2026
AbandonedAbandoned Feb 18, 2026
17/760,861Sulfonamide Derivatives as CTPS1 Inhibitors
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/980,186Compositions Related to Substituted Pyrazines as CTPS Inhibitors
Abandoned
Abandoned Aug 15, 2025
AbandonedAbandoned Aug 15, 2025
18/842,972Combinations of CTPS1 and BCL2 Inhibitors for Cancer
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/140,541CTPS1 Inhibitors for Use in the Treatment of CTPS2 Deficient Cancer
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/203,129Compounds
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/217,739Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/357,600N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited